Generic Name Brand Name
cetuximab Erbitux

How It Works

Cetuximab belongs to a group of drugs known as monoclonal antibodies. It blocks a protein called epidermal growth factor that helps cancer cells grow and multiply. Cetuximab is an intravenous (IV) drug.

Why It Is Used

Cetuximab is used alone or in combination with other chemotherapy drugs to treat metastatic or recurrent colorectal cancer.

How Well It Works

Cetuximab helps some other chemotherapy drugs work better than they do alone. For example, when used with irinotecan, cetuximab slows tumor growth in approximately 23% of people who have metastatic or recurrent colorectal cancer.1

Side Effects

Cetuximab can cause serious side effects, usually during the first treatment. Side effects may include:

  • Difficulty breathing.
  • Low blood pressure.
  • Scarring of the lungs (interstitial lung disease).
  • Skin rash.
  • Dry skin.
  • Weakness and fatigue.
  • Fever.
  • Constipation.
  • Abdominal pain.

Cetuximab may cause more serious side effects, such as loss of consciousness, shock, cardiac arrest, and not being able to breathe. The Food and Drug Administration (FDA) says that people who take this medicine should be watched closely while they are getting this medicine and for 1 hour afterward.

The FDA also warns that some people may get a severe rash and/or infections when they take this medicine.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Cetuximab should be administered only under the supervision of a medical oncologist.

Cetuximab may cause birth defects. Do not use this medication if you are pregnant or wish to become pregnant or father a child while you are taking it.

Cetuximab has been approved for use only in adults. There is no specific information comparing use of cetuximab in children with its use in other age groups.

Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.



  1. Venook A (2005). Critical evaluation of current treatments of metastatic colorectal cancer. Oncologist, 10(4): 250–261.

Last Updated: October 1, 2008

related physicians

related services

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.